REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2012

Jan 4, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REGENERON PHARMACEUTICALS INC (REGN)
CIK: 0000872589
Period of Report: 2012-01-03

Reporting Person: SHOOTER ERIC M (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-06-03	Class A Stock	$0	G	20000	Acquired		Common Stock (20000)	Indirect
2011-06-03	Class A Stock	$0	G	20000	Acquired		Common Stock (20000)	Indirect
2011-06-03	Class A Stock	$0	G	40000	Disposed		Common Stock (40000)	Indirect
2012-01-03	Non-Qualified Stock Option (right to buy)	$57.11	A	15000	Acquired	2022-01-03	Common Stock (15000)	Direct

Footnotes

F1: Class A Stock of Regeneron Pharmaceuticals, Inc. ("Regeneron") converts to Common Stock of Regeneron on a one-to-one basis upon certain events.

F2: 40,000 shares of Class A Stock were distributed by the Shooter Family Trust in equal amounts to each of the reporting person and his spouse, the beneficiaries of the Shooter Family Trust. Upon receipt of such shares, each of the reporting person and his spouse contributed such shares to a grantor retained annuity trust for the benefit of such person and the remaindermen, an adult child and her children.

F3: The reporting person and his spouse are co-trustees and beneficiaries of the Shooter Family Trust.

F4: The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant

F5: Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.